Press Releases

PARAMUS, N.J., Nov. 25, 2019 /PRNewswire/ -- Ichnos Sciences Inc. is pleased to announce the appointment of Dr. Marcela Maus, MD, PhD to its Board of Directors. Dr. Maus is currently an Assistant Professor at Harvard Medical School, Director of Cellular Immunotherapy at Massachusetts General Hospital (MGH) C

CALGARY, Nov. 25, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX."Listing on the TSX is a significant milestone for W

TAMPA, Fla., Nov. 25, 2019 /PRNewswire/ -- INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercializ

-  Tumor control rate of 82% in recurrent glioblastoma following one treatment with MDNA55-  Median overall survival of 15 months in patients over-expressing the IL4R-  Meetings with regulatory agencies planned for early 2020 TORONTO and HOUSTON, Nov. 25, 2019 /P

DUSSELDORF, Germany, Nov. 25, 2019 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, presented its latest products and technologies in the world's largest medical event Medica: its first echoendoscope EG-UR5 (endoscopic ultrasound), a new 4-LED light source and SFI/VIST technology for endoscopy HD550, and

Received inaugural purchase order from British Columbia Advancing TGOD's access to retail locations with the addition of British Columbia's 163 stores Ability to distribute to a total of 527 retail outlets across five provinces Obtained licence amendment from Health Canada to start cultivation operations at

TORONTO, Nov. 25, 2019 /PRNewswire/ - Two of ACTO's use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the 'Most Promising MVP/Pilot' category for its ACTO use case. ACTO has been nominated in t

HOUSTON, Nov. 25, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its President and Chief Executive Office

MONMOUTH JUNCTION, N.J., Nov. 25, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO) is temporarily pausing enrollment of its REFRESH 2-AKI s

DUBLIN, Nov. 25, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has completed its previously announced acquisition of Rodin Therapeutics, Inc. (Rodin), a privately